Sponsor or institution
Clinical trials and research at ModeX Therapeutics, An OPKO Health Company
As of November 12, 2026, Find a Trial lists 4 clinical trials run by ModeX Therapeutics, An OPKO Health Company that are recruiting, at sites in 4 countries (most in Australia (2), Israel (2), United States (2)). By phase: Phase 1/2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MDX2301 in healthy adults and adults at higher risk for severe COVID-19 | Phase 1 | Las Vegas, Nevada and 1 other locations | Recruiting | Mar 3, 2026 |
| MDX2003 for adults with relapsed B‑cell lymphomas | Phase 1/2 | Richmond, Victoria and 6 other locations | Recruiting | Nov 25, 2025 |
| Testing MDX2004 at increasing doses in adults with advanced tumors | Phase 1/2 | Liverpool, New South Wales and 5 other locations | Recruiting | Aug 7, 2025 |
| Testing MDX2001 for advanced solid tumors | Phase 1/2 | Denver, Colorado and 5 other locations | Recruiting | Feb 2, 2024 |
All recruiting trials (4)
-
MDX2301 in healthy adults and adults at higher risk for severe COVID-19
This study will try single and repeat doses of MDX2301 given by IV, IM, or SC to see if they are safe and trigger neutralizing activity in healthy adults and adults at higher risk for severe COVID-19.
-
MDX2003 for adults with relapsed B‑cell lymphomas
This trial will test MDX2003 in adults with relapsed or refractory B‑cell lymphomas whose tumors are CD19 or CD20 positive to see if it is safe and can shrink tumors.
-
Testing MDX2004 at increasing doses in adults with advanced tumors
This will test whether different doses of the experimental drug MDX2004 are safe and can shrink tumors in adults with advanced or metastatic cancer.
-
Testing MDX2001 for advanced solid tumors
This study is testing a new drug called MDX2001 to see if it can safely help people with advanced solid tumors like breast or colon cancer.
Quick answers
How many clinical trials run by ModeX Therapeutics, An OPKO Health Company are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Australia (2 trials), Israel (2 trials), United States (2 trials), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.